{"id":"W4416391806","doi":"10.1016/j.annonc.2025.09.113","title":"LBA96 First-line pembrolizumab-based regimens for advanced clear cell renal cell carcinoma: KEYMAKER-U03 substudy 03A","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Genentech; European Association of Urology","keywords":"Clear cell renal cell carcinoma; Pembrolizumab; Clear cell; Renal cell carcinoma; Cell","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009158977,0.0002675463,0.00129915,0.0004299622,0.0007142536,0.001097703,0.0005469905,0.0004463332,0.004107149],"category_scores_gemma":[0.001103094,0.0002173392,0.0009328404,0.001324583,0.0002382496,0.0009088178,0.0003249218,0.001471312,0.0008437411],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001939122,"about_ca_system_score_gemma":0.001196165,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005888642,"about_ca_topic_score_gemma":0.02435984,"domain_scores_codex":[0.999524,0.0001466506,0.00004977335,0.00006997319,0.00008898973,0.0001205389],"domain_scores_gemma":[0.9994037,0.0001462468,0.0001540876,0.00006528783,0.00007060267,0.0001600913],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.0691203,0.002087278,0.2764088,0.003539892,0.005687208,0.001719263,0.0004706359,0.002610009,0.018913,0.002732773,0.08907761,0.5276332],"study_design_scores_gemma":[0.02416585,0.02167637,0.7226508,0.001397026,0.007825477,0.007165857,0.0004167987,0.004682968,0.01155899,0.003642723,0.1946749,0.000142339],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9048314,0.03058429,0.000952438,0.00246906,0.0003968033,0.0009529559,0.02658682,0.0002718778,0.03295432],"genre_scores_gemma":[0.9654267,0.007142553,0.001267103,0.00161018,0.0002158399,0.0005697674,0.01864145,0.00006124031,0.00506527],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005888642,"threshold_uncertainty_score":0.01406938,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0601033545602204,"score_gpt":0.3554252284109267,"score_spread":0.2953218738507063,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}